{"id":82286,"date":"2025-05-07T16:24:08","date_gmt":"2025-05-07T16:24:08","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/82286\/"},"modified":"2025-05-07T16:24:08","modified_gmt":"2025-05-07T16:24:08","slug":"une-nouvelle-molecule-capable-de-detruire-des-cellules-resistantes-a-la-chimiotherapie","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/82286\/","title":{"rendered":"une nouvelle mol\u00e9cule capable de d\u00e9truire des cellules r\u00e9sistantes \u00e0 la chimioth\u00e9rapie"},"content":{"rendered":"<p><strong>D\u00c9CRYPTAGE <\/strong>&#8211; Une \u00e9quipe fran\u00e7aise a mis au point une mol\u00e9cule potentiellement capable de venir \u00e0 bout de cancers de tr\u00e8s mauvais pronostic.<\/p>\n<p class=\"fig-paragraph\">C\u2019est une petite mol\u00e9cule mise au point par des chercheurs fran\u00e7ais, qui n\u2019en est qu\u2019\u00e0 ses balbutiements mais qui pourrait changer radicalement la donne dans\u00a0<a href=\"http:\/\/www.lefigaro.fr\/sciences\/dossier\/cancer-guerir-maladie-immunotherapie-chimiotherapie-cellules-cancereuses-sante\" data-fig-type=\"Topic\" data-gtm-custom-categorie=\"navigation\" data-gtm-custom-action=\"crossclick\" data-gtm-custom-label=\"Contextuel\" data-gtm-event=\"customEventSPE\" data-fig-domain=\"LEFIGARO\" target=\"_blank\" rel=\"noopener\">la lutte contre le cancer.<\/a>\u00a0Depuis quelques d\u00e9cennies, les traitements ont permis des progr\u00e8s ph\u00e9nom\u00e9naux et le cancer n\u2019est plus une condamnation \u00e0 mort. Mais malgr\u00e9 la puissance notamment des\u00a0<a href=\"https:\/\/www.lefigaro.fr\/sciences\/cancer-simplifier-l-injection-de-la-chimiotherapie-20221005\" data-fig-type=\"Article\" data-gtm-custom-categorie=\"navigation\" data-gtm-custom-action=\"crossclick\" data-gtm-custom-label=\"Contextuel\" data-gtm-event=\"customEventSPE\" data-fig-domain=\"LEFIGARO\" target=\"_blank\" rel=\"noopener\">tr\u00e8s nombreuses chimioth\u00e9rapies<\/a>\u00a0existantes, trop de malades rechutent. Les traitements deviennent alors beaucoup moins efficaces\u00a0: \u00ab70% des gens qui meurent de cancer ne meurent pas \u00e0 cause de leur tumeur primaire, mais de m\u00e9tastases\u00bb, souligne Rapha\u00ebl Rodriguez, directeur de recherche CNRS \u00e0 l\u2019Institut Curie, qui \u00e9tudie notamment le r\u00f4le des m\u00e9taux dans la biologie du cancer. Avec son \u00e9quipe, il a d\u00e9velopp\u00e9 une mol\u00e9cule d\u2019une toute nouvelle classe th\u00e9rapeutique, capable de cibler ces cancers m\u00e9tastatiques contre lesquels la m\u00e9decine est d\u00e9munie.<\/p>\n<p class=\"fig-paragraph\">Les m\u00e9tastases sont le fait de cellules canc\u00e9reuses qui se diss\u00e9minent dans l\u2019organisme et qui\u2026<\/p>\n<p class=\"fig-premium-paywall__infos\">\n        Cet article est r\u00e9serv\u00e9 aux abonn\u00e9s.        Il vous reste 83% \u00e0 d\u00e9couvrir.\n    <\/p>\n<p>                <img  data- alt=\"Le Figaro\" class=\"fig-img--complete fig-img\"\/><\/p>\n<p class=\"fig-premium-paywall__title\">Je m&rsquo;informe, je m&rsquo;inspire, je m&rsquo;abonne.<\/p>\n<p class=\"fig-premium-paywall__subtitle\">D\u00e9couvrez notre offre de bienvenue.<\/p>\n<p class=\"fig-premium-paywall__connect\">\n                D\u00e9j\u00e0 abonn\u00e9\u00a0?                <a class=\"fig-premium-paywall__connect-link\" href=\"https:\/\/connect.lefigaro.fr\/login?client=sante_web&amp;type=main&amp;redirect_uri=https%3A%2F%2Fsante.lefigaro.fr%2Fmedecine%2Fcancer-une-nouvelle-molecule-capable-de-detruire-des-cellules-resistantes-a-la-chimiotherapie-20250507\" data-js-gtm=\"{&quot;customCategorie&quot;: &quot;conversion&quot;, &quot;customAction&quot;: &quot;before_Landing_Connexion_paywall_auto&quot;, &quot;customLabel&quot;: &quot;c2FudGUubGVmaWdhcm8uZnJfXzFmMDJhNzgxLWQ1ZmEtNjU4YS05OWZiLTZmYmRlZjBhMzE4Yl9fQXJ0aWNsZQ==_Cancer\u00a0: une nouvelle mol\u00e9cule capable de d\u00e9truire des cellules r\u00e9sistantes \u00e0 la chimioth\u00e9rapie_92&quot;, &quot;customIDSPE&quot;: &quot;c2FudGUubGVmaWdhcm8uZnJfXzFmMDJhNzgxLWQ1ZmEtNjU4YS05OWZiLTZmYmRlZjBhMzE4Yl9fQXJ0aWNsZQ==&quot;, &quot;event&quot;: &quot;customEventSPE&quot;}\" target=\"_blank\" rel=\"noopener\"><br \/>\n                    Connectez-vous<br \/>\n                <\/a>\n            <\/p>\n","protected":false},"excerpt":{"rendered":"D\u00c9CRYPTAGE &#8211; Une \u00e9quipe fran\u00e7aise a mis au point une mol\u00e9cule potentiellement capable de venir \u00e0 bout de&hellip;\n","protected":false},"author":2,"featured_media":82287,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[237,101,232,231,234,228,1011,27,72,239,230,238,226,224,225,233,229,236,235,71,227],"class_list":{"0":"post-82286","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-actualite-sur-les-maladies","9":"tag-cancer","10":"tag-cardiologie","11":"tag-cerveau","12":"tag-diabete","13":"tag-diagnostic","14":"tag-fr","15":"tag-france","16":"tag-health","17":"tag-info-sur-les-maladies","18":"tag-infographie","19":"tag-information-sur-les-maladies","20":"tag-maladie","21":"tag-medecine","22":"tag-medicament","23":"tag-obesite","24":"tag-pathologie","25":"tag-pediatrie","26":"tag-psychiatrie","27":"tag-sante","28":"tag-traitement"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/114467482110829711","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/82286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=82286"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/82286\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/82287"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=82286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=82286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=82286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}